Abstract
Estrogen receptor β (ERβ) is an important mediator of estrogen function in a variety of tissues. Its expression declines in breast, ovarian, prostatic and colon carcinomas as well as in astrocytic tumours. BAG-1 is a multifunctional protein with an important role in neoplasia and is possibly regulated by estrogen receptors. One of the direct targets of BAG-1 is HSP70. The purpose of this study was to analyse the expression pattern of these proteins in two distinct types of glial neoplasms, to investigate their possible correlation and probe their impact on prognosis. ERβ, BAG-1 and HSP70 protein expression was monitored immunohistochemically in 66 cases of astrocytomas and 20 oligodendrogliomas. In astrocytic tumours low ERβ expression correlated significantly with high grade (P < 0.001), higher expression of cytoplasmic BAG-1 (P < 0.001) and worse survival (log rank P = 0.02). Multivariate analysis revealed that ERβ expression had a prognostic value for overall survival in these patients (Cox P = 0.03), which was not dependent on grade. There was also statistically significant association of BAG-1 nuclear expression with HSP70 cytoplasmic expression. Our results strengthen the hypothesis that ERβ, BAG-1 and HSP70 play an important role in the pathogenesis and progression of glial neoplasms. Moreover, ERβ expression in astrocytic tumors might be an important prognostic factor for survival.
Similar content being viewed by others
References
Green S, Walter P, Kumar V, Krust A, Bornert JM, Argos P, et al. (1986) Human estrogen receptor cDNA: sequence, expression and homology to v-erb-A Nature 320:134–139
Greene GL, Gilna P, Waterfield M, Baker A, Hort Y, Shine J, (1986) Sequence and expression of human estrogen complementary DNA Science 231:1150–1154
Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA, (1996) Cloning of a novel receptor expressed in rat prostate and ovary Proc Natl Acad Sci 93:5925–5990
Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, et al. (1995) The nuclear receptor supefamily: the second decade Cell 83:835–839
Mosselman S, Polman J, Dijkema R, (1996) ER-β: identification and characterization of novel human estrogen receptor FEBS Lett 392:49–53
Batistatou A, Stefanou D, Goussia A, Arkoumani E, Papavassiliou A, Agnantis NJ. Estrogen receptor beta, (ERβ) is expressed in brain astrocytic tumors and declines with dedifferentiation of the neoplasm. J Cancer Res Clin Oncol May 13 2004 [Epub ahead of print]
Deyrup AT, Tretiakova M, Khramtsov A, Montag AG. Estrogen receptor beta expression in vascular neoplasia: an analysis of 53 benign and malignant cases. Mod Pathol Jul 2 2004 [Epub ahead of print]
Konstantinopoulos PA, Kominea A, Vandoros G, Sykiotis GP, Andricopoulos P, Varakis I, et al. (2003) Oestrogen receptor beta (ERβ) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumors dedifferentiation Eur J Cancer 39:1251–1258
Pujol P, Rey JM, Nirde P, Roger P, Gastaldi M, Laffargue F, et al. (1998) Differential expression of estrogen receptor-α and -β messanger RNAs as a potential marker of ovarian carcinogenesis Cancer Res 58:5367–5373
Speirs V, (2002) Oestrogen receptor β in breast cancer: good, bad or still too early to tell? J Pathol 197:143–147
Cutress RI, Townsend PA, Sharp A, Maison A, Wood L, Lee R, et al. (2003) The nuclear BAG-1 isoform, BAG-1L, enhances oestrogen-dependent trascription Oncogene 22:4973–4982
Kullmann M, Schneikert J, Moll J, Heck S, Zeiner M, Gehring U, et al. (1998) RAP46 is a negative regulator of glucocorticoid receptor action and hormone-induced apoptosis J Biol Chem 273:14620–14625
Schneikert J, Hubner S, Martin E, Cato AC, (1999) A nuclear action of the eukaryotic cochaperone RAP46 in downregulation of glucocorticoid receptor activity J Cell Biol 146:29–940
Takayama S, Sato T, Krajewski S, Kochel K, Irie S, Millan JA, et al. (1995) Cloning and functional analysis of BAG-1: a novel Bcl-2-binding protein with anti-cell death activity Cell 80:279–284
Wang HG, Takayama S, Rapp UR, Reed JC, (1996) Bcl-2 interacting protein, BAG-1, binds to and activates the kinase Raf-1 Proc Natl Acad Sci USA 93:7063–7068
Zeiner M, Gehring U, (1995) A protein that interacts with members of the nuclear hormone receptor family: identification and cDNA cloning Proc Natl Acad Sci USA 92:11465–11469
Zeiner M, Niyaz Y, Gehring U, (1999) The hsp70-associating protein Hap46 binds to DNA and stimulates transcription Proc Natl Acad Sci USA 96: 10194–10199
Townsend PA, Cutress RI, Sharp A, Brimmell M, Packham G, (2003) BAG-1 prevents stress-induced long-term growth inhibition in breast cancer cells via a chaperone-dependent pathway Cancer Res 63:4150–4157
Cutress RI, Townsend PA, Brimmell M, Bateman AC, Hague A, Packham G, (2000) BAG-1 expression and function in human cancer Br J Cancer 87:834–839
Brimmell M, Burns JS, Munson P, McDonald L, O’Hare MJ, Lakhani SR, et al. (1999) High level of differentially localized BAG-1 isoforms in some oestrogen receptor-positive human breast cancers Br J Cancer 81:1042–1051
Sjostrom J, Blomqvist C, von Boguslawski K, Bengtsson NO, Mjaaland I, Malmstrom P, et al. (2002) The predictive value of bcl-2, bax, bcl-xL, bag-1, fas, and fasL for chemotherapy response in advanced breast cancer Clin Cancer Res 8:811–816
Tang SC Shehata N, Chernenko G, Khalifa M, Wang X, Shaheta N, (1999) Expression of BAG-1 in invasive breast carcinomas J Clin Oncol 17:1710–1719
Tang SC, Beck J, Murphy S, Chernenko G, Robb D, Watson P, et al. (2004) BAG-1 expression correlates with Bcl-2, p53, differentiation, estrogen and progesterone receptors in invasive breast carcinoma Breast Cancer Res Treat 84:203–213
Turner BC, Krajewski S, Krajewska M, Takayama S, Gumbs AA, Carter D, et al. (2001) BAG-1: a novel biomarker predicting long-term survival in early-stage breat cancer J Clin Oncol 19:992–1000
Rorke S, Murphy S, Khalifa M, Chernenko G, Tang SC, (2001) Prognostic significance of BAG-1 expression in non-small cell lung cancer Int J Cancer 95:317–322
Niyaz Y, Zeiner M, Gehring U, (2001) Transcriptional activation by the human Hsp70-associating protein Hap50 J Cell Sci 114:1839–1845
Ciocca DR, Clark GM, Tandon AK, Fuqua SA, Welch WJ, McGuire WL, (1993) Heat shock protein hsp70 in patients with axillary lymph node negative breast cancer: prognostic implications J Natl Cancer Inst 59:570–574
Young JC, Barral JM, Hartl FU, (2003) More than folding: localized functions of cytosolic chaperones Trends Biochem Sci 28:541–547
Kleihues P, Cavenee WK. WHO, Pathology and Genetics. Tumors of the nervous system (1st ed). IARC Press, Lyon, 2004
Louis DN, Holland EC, Cairncross JG, (2001) Glioma classification: A molecular reappraisal Am J Pathol 159:779–786
Townsend PA, Dublin E, Hart IR, Kao RH, Hanby AM, Cutress RI, et al. (2002) BAG-1 expression in human breast cancer: interrelationship between BAG-1 RNA, protein, HSC70 expression and clinico-pathological data J Pathol 197:51–59
Chaidarun SS, Swearingen B, Alexander J, (1998) Differential expression of estrogen receptor beta (ER beta) in human pituitary tumors: functional interactions with ER alpha and a tumor-specific splice variant J Clin Endocrinol Metab 83:3308–3315
Savaskan E, Olivieri G, Meirer F, Ravid R, Muller-Spahn F, (2001) Hippocampal estrogen beta-receptor immunoreactivity is increased in Alzheimer’s disease Brain Res 908:113–119
Assimakopoulou M, Sotiropoulou-Bonikou G, Maraziotis T, Varakis J, (1998) Does sex steroid receptor status have any prognostic or predictive significance in brain astrocytic tumors? Clin Neuropathol 17:27–34
Carroll RS, Zhang J, Dashnr K, Sar M, Black PM, (1995) Steroid hormone receptors in astrocytic neoplasms Neurosurgery 37:496–503
Khalid H, Yaunaga A, Kishikawa M, Shibata S, (1995) Immunohistochemical expression of the estrogen receptor-related antigen (ER-D5) in human intracranial tumors Cancer 75:2571–2580
Shiraishi T, Tabuchi K, (2003) Genetic alterations of human brain tumors as molecular prognostic factors Neuropathology 23:95–108
Xu S, Zhu X, Zhang S, Yin S, Zhou L, Chen C, et al. (2001) Over-expression of 1,4-galactosyltransferase I, II, and V in human astrocytoma J Cancer Res Clin Oncol 127:502–506
Yamauchi H, Adachi M, Sakata K, Hareyama M, Satoh M, Himi T, et al. (2001) Nuclear BAG-1 localisation and the risk of recurrence after radiation therapy in laryngeal carcinoma Cancer Lett 165:103–110
Kermer P, Krajewska M, Zapata JM, Takayama S, Mai J, Krajewski S, et al. (2002) Bag1 is a regulator and marker of neuronal differentiation Cell Death Differ 9:405–413
Roth W, Grimmel C, Rieger L, Strik H, Takayama S, Krajewski S, et al. (2000) Bag-1 and Bcl-2 gene transfer in malignant glioma: modulation of cell cycle regulation and apoptosis Brain Pathol 10: 223–234
Engelhard HH, Stelea A, Cochran EJ, (2002) Oligodendroglioma: Pathology and Molecular Biology Surg Neurol 58:111–117
Kounelis S, Kapranos N, Kouri E, Coppola D, Papadaki H, Jones MW, (2000) Immunohistochemical profile of endometrial adenocarcinoma: a study of 61 cases and review of the literature Mod Pathol 13:379–388
Strik HM, Weller M, Frank B, Hermisson M, Deininger MH, Dichgans J, et al. (2000) Heat shock protein expression in human gliomas Anticancer Res 20:4457–4462
Tang SC, (2002) BAG-1, an anti-apoptotic tumour marker IUBMB Life 53: 99–105
Acknowledgements
We thank A. Christodoulou for excellent technical assistance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Batistatou, A., Kyzas, P.A., Goussia, A. et al. Estrogen receptor beta (ERβ) protein expression correlates with BAG-1 and prognosis in brain glial tumours. J Neurooncol 77, 17–23 (2006). https://doi.org/10.1007/s11060-005-9005-0
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-005-9005-0